StockData
Bright Minds Biosciences Inc. logo

Bright Minds Biosciences Inc. (DRUG) stock

DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Sep 30, 2025Last filing: 40-F on Dec 23, 2025Score 5/30
$20.70−0.06 (-0.29%)

Close on Nov 19, 2026Market cap $158.06MP/E –Yield –

Bright Minds Biosciences r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was C$11.08M, up 839.4% from the year before. The highest annual figure on record is C$12.18M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Sep 30, 2025C$11.08M+839.4%
FY2024Sep 30, 2024C$1.18M-76.4%
FY2023Sep 30, 2023C$5.00M-59.0%
FY2022Sep 30, 2022C$12.18M+92.9%
FY2021Sep 30, 2021C$6.31M+1679.3%
FY2020Sep 30, 2020C$354.85K–

More Bright Minds Biosciences figures

See a number that looks wrong?